Blastic Plasmacytoid Dendritic Cell Leukemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation to a Remission of 48-Month Duration

Blastic Plasmacytoid Dendritic Cell Leukemia Successfully Treated by Autologous Hematopoietic Stem Cell Transplantation to a Remission of 48-Month Duration

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a very rare subtype of AML characterized by the clonal proliferation of precursors of plasmacytoid dendritic cells. It presents with an aggressive behavior. The clinical findings include cytopenia, particularly thrombocytopenia. Although it res...

Full description

Bibliographic Details
Main Authors: Goren Sahin, Deniz, Akay, Olga Meltem, Üsküdar Teke, Hava, Andıc, Neslihan, Gunduz, Eren, Gulbas, Zafer
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2013
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874354/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874354/

Similar Items